After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is scooping up the biotech for $2.5 billion. At the heart of the buyout is ...
Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ...
Pete’s previous limited experience with a longboard was BAD…but who better to try it again with than the 3-time World ...
Longboard Pharmaceuticals LBPH gained 14.4% on Jul 1 after it announced that the FDA has granted Breakthrough Therapy designation for its investigational drug, bexicaserin, to treat seizures ...
Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...
If you don't know much about skateboards or longboards, it may be tricky to tell the difference between them. Believe it or not, both boards have entirely different uses. When picking which would be ...
Are you looking for the perfect board for you? We've tallied up the biggest differences between a longboard and a skateboard to help you decide. If you don't know much about skateboards or longboards, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback